MK-3543, MK-3543, MK-3543, MK-3543
MK-3543-017
Phase 3 small_molecule active
Quick answer
MK-3543, MK-3543, MK-3543, MK-3543 for Myeloproliferative Neoplasms (Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis) is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Myeloproliferative Neoplasms (Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active